| Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo … EL Simpson, R Sinclair, S Forman, A Wollenberg, R Aschoff, M Cork, ... The Lancet 396 (10246), 255-266, 2020 | 442 | 2020 |
| Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: a randomized clinical trial JI Silverberg, EL Simpson, JP Thyssen, M Gooderham, G Chan, C Feeney, ... JAMA dermatology 156 (8), 863-873, 2020 | 379 | 2020 |
| Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration G Scott, H Zetterberg, A Jolly, JH Cole, S De Simoni, PO Jenkins, ... Brain 141 (2), 459-471, 2018 | 198 | 2018 |
| Cognitive impairment and health-related quality of life following traumatic brain injury N Gorgoraptis, J Zaw-Linn, C Feeney, C Tenorio-Jimenez, M Niemi, ... NeuroRehabilitation 44 (3), 321-331, 2019 | 148 | 2019 |
| Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis: the JADE TEEN randomized clinical trial LF Eichenfield, C Flohr, R Sidbury, E Siegfried, Z Szalai, R Galus, Z Yao, ... JAMA dermatology 157 (10), 1165-1173, 2021 | 140 | 2021 |
| Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: results from the JAK1 Atopic Dermatitis Efficacy and Safety … A Blauvelt, JI Silverberg, CW Lynde, T Bieber, S Eisman, J Zdybski, ... Journal of the American Academy of Dermatology 86 (1), 104-112, 2022 | 135 | 2022 |
| The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance CL Tan, SA Alavi, SE Baldeweg, A Belli, A Carson, C Feeney, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (11), 971-981, 2017 | 109 | 2017 |
| Pituitary dysfunction after blast traumatic brain injury: The UK BIOSAP study D Baxter, DJ Sharp, C Feeney, D Papadopoulou, TE Ham, S Jilka, ... Annals of neurology 74 (4), 527-536, 2013 | 104 | 2013 |
| Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain C Feeney, G Scott, J Raffel, S Roberts, C Coello, A Jolly, G Searle, ... European journal of nuclear medicine and molecular imaging 43, 2201-2210, 2016 | 89 | 2016 |
| The epidemiology of eczema in children and adults in England: a population‐based study using primary care data S de Lusignan, H Alexander, C Broderick, J Dennis, A McGovern, ... Clinical & Experimental Allergy 51 (3), 471-482, 2021 | 77 | 2021 |
| Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injury OA Jamall, C Feeney, J Zaw‐Linn, A Malik, MEK Niemi, ... Clinical endocrinology 85 (4), 636-644, 2016 | 46 | 2016 |
| Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study S de Lusignan, H Alexander, C Broderick, J Dennis, A McGovern, ... Journal of Allergy and Clinical Immunology 150 (3), 709-713, 2022 | 45 | 2022 |
| Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis JP Thyssen, G Yosipovitch, C Paul, SG Kwatra, CY Chu, ... Journal of the European Academy of Dermatology and Venereology 36 (3), 434-443, 2022 | 39 | 2022 |
| Impact of oral abrocitinib monotherapy on patient-reported symptoms and quality of life in adolescents and adults with moderate-to-severe atopic dermatitis: a pooled analysis … JI Silverberg, JP Thyssen, EL Simpson, G Yosipovitch, S Ständer, ... American journal of clinical dermatology 22 (4), 541-554, 2021 | 38 | 2021 |
| Patterns and trends in eczema management in UK primary care (2009–2018): a population‐based cohort study S de Lusignan, H Alexander, C Broderick, J Dennis, A McGovern, ... Clinical & Experimental Allergy 51 (3), 483-494, 2021 | 29 | 2021 |
| Non-EPI-DWI for detection, disease monitoring, and clinical decision-making in thyroid eye disease C Feeney, RK Lingam, V Lee, F Rahman, S Nagendran American Journal of Neuroradiology 41 (8), 1466-1472, 2020 | 29 | 2020 |
| Serum insulin‐like growth factor‐I levels are associated with improved white matter recovery after traumatic brain injury C Feeney, DJ Sharp, PJ Hellyer, AE Jolly, JH Cole, G Scott, D Baxter, ... Annals of Neurology 82 (1), 30-43, 2017 | 29 | 2017 |
| Do medical outpatients want'out of hours' clinics? CL Feeney, NJ Roberts, MR Partridge BMC Health Services Research 5, 1-4, 2005 | 23 | 2005 |
| Predictors of nonresponse to dupilumab in patients with atopic dermatitis: a machine learning analysis JJ Wu, C Hong, JF Merola, D Gruben, E Güler, C Feeney, A Bhambri, ... Annals of Allergy, Asthma & Immunology 129 (3), 354-359. e5, 2022 | 17 | 2022 |
| Early itch response with abrocitinib is associated with later efficacy outcomes in patients with moderate-to-severe atopic dermatitis: Subgroup analysis of the randomized Phase … S Ständer, SG Kwatra, JI Silverberg, EL Simpson, JP Thyssen, ... American journal of clinical dermatology 24 (1), 97-107, 2023 | 15 | 2023 |
